Invasive monitoring: should we place it in all HF patients?
Mazimba, Sula
(
University of Virginia
, Charlottesville , Virginia , United States )
De Boer, Rudolf
(
Erasmus MC
, Rotterdam , Netherlands )
Brugts, Jan Jasper
(
ERASMUS MC THORAXCENTER
, Rotterdam , Netherlands )
Author Disclosures:
Sula Mazimba:DO NOT have relevant financial relationships
| Rudolf De Boer:DO have relevant financial relationships
;
Research Funding (PI or named investigator):European Researc Council:Active (exists now)
; Advisor:Medtronic:Active (exists now)
; Speaker:Zoll:Past (completed)
; Speaker:NovoNordisk:Active (exists now)
; Speaker:AstraZeneca:Past (completed)
; Speaker:Abbott:Past (completed)
; Research Funding (PI or named investigator):Abbott:Active (exists now)
; Research Funding (PI or named investigator):NovoNordisk:Active (exists now)
; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now)
; Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
; Research Funding (PI or named investigator):Alnylam:Active (exists now)
; Research Funding (PI or named investigator):Netherlands Heart Foundation:Active (exists now)
| Jan Jasper Brugts:DO have relevant financial relationships
;
Speaker:Astra Zeneca:Past (completed)
; Speaker:Vifor:Past (completed)
; Speaker:Novartis:Past (completed)
; Speaker:Boehringer:Past (completed)
; Speaker:Abbott:Past (completed)